Pharmaceutical manufacturers’ supply chains are becoming more complex in our globalized economy. With sales ranging from $163 billion to $217 billion per year, counterfeit pharmaceuticals are the largest segment of fraudulent goods sold worldwide every year. For consumer safety and brand integrity, you need the right authentication solutions to thrive within the pharmaceutical supply and distribution chain.
Proactively identifying those medicines “at risk” of being counterfeited is the first step to stopping potential threats, pinpointing the gaps in your supply chain and preventing counterfeit medicines from entering the marketplace.
Take our risk assessment survey to protect your consumers and your brand.